D. E. AUER

456 total citations
22 papers, 334 citations indexed

About

D. E. AUER is a scholar working on Equine, Pharmacology and Small Animals. According to data from OpenAlex, D. E. AUER has authored 22 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Equine, 7 papers in Pharmacology and 5 papers in Small Animals. Recurrent topics in D. E. AUER's work include Veterinary Equine Medical Research (12 papers), Inflammatory mediators and NSAID effects (4 papers) and Pharmacology and Obesity Treatment (3 papers). D. E. AUER is often cited by papers focused on Veterinary Equine Medical Research (12 papers), Inflammatory mediators and NSAID effects (4 papers) and Pharmacology and Obesity Treatment (3 papers). D. E. AUER collaborates with scholars based in Australia, United States and Myanmar. D. E. AUER's co-authors include A. A. Seawright, Allen L. Rodgers, P. C. Mills, A. A. Seawright, FC BALDOCK, Daniel W. Barry, J. C. Ng, K. Bell, Joseph Thornton and C. C. Pollitt and has published in prestigious journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Equine Veterinary Journal and Australian Veterinary Journal.

In The Last Decade

D. E. AUER

22 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. E. AUER Australia 12 127 80 42 42 40 22 334
Jim Moore United States 13 155 1.2× 54 0.7× 26 0.6× 38 0.9× 10 0.3× 28 348
Michael L. Keowen United States 12 276 2.2× 136 1.7× 8 0.2× 127 3.0× 51 1.3× 31 447
Qiao Zhong China 16 99 0.8× 34 0.4× 12 0.3× 89 2.1× 9 0.2× 36 601
L.K. Warren United States 16 254 2.0× 40 0.5× 21 0.5× 203 4.8× 87 2.2× 69 674
Toshinori Sako Japan 12 17 0.1× 92 1.1× 49 1.2× 30 0.7× 36 0.9× 68 451
Faith E. Hughes United States 10 342 2.7× 169 2.1× 13 0.3× 130 3.1× 33 0.8× 25 417
Ramberg Cf United States 10 57 0.4× 110 1.4× 8 0.2× 258 6.1× 60 1.5× 14 468
Chadwick E. Dodd United States 5 99 0.8× 172 2.1× 22 0.5× 2 0.0× 19 0.5× 7 343
Christopher Macdonald United Kingdom 6 11 0.1× 253 3.2× 146 3.5× 44 1.0× 38 0.9× 6 768
Tisha A.M. Harper United States 13 31 0.2× 169 2.1× 19 0.5× 3 0.1× 8 0.2× 32 413

Countries citing papers authored by D. E. AUER

Since Specialization
Citations

This map shows the geographic impact of D. E. AUER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. E. AUER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. E. AUER more than expected).

Fields of papers citing papers by D. E. AUER

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. E. AUER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. E. AUER. The network helps show where D. E. AUER may publish in the future.

Co-authorship network of co-authors of D. E. AUER

This figure shows the co-authorship network connecting the top 25 collaborators of D. E. AUER. A scholar is included among the top collaborators of D. E. AUER based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. E. AUER. D. E. AUER is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
AUER, D. E., et al.. (1998). The Effect of Ascorbic Acid Ingestion on the Biochemical and Physicochemical Risk Factors Associated with Calcium Oxalate Kidney Stone Formation. Clinical Chemistry and Laboratory Medicine (CCLM). 36(3). 143–148. 46 indexed citations
2.
AUER, D. E., et al.. (1998). Effects of inflammation‐associated acute‐phase response on hepatic and renal indices in the horse. Australian Veterinary Journal. 76(3). 187–194. 34 indexed citations
3.
Mills, P. C., J. C. Ng, & D. E. AUER. (1997). The Effect of the Acute-Phase Response on In Vitro Drug Metabolism and Plasma Protein Binding in the Horse. Veterinary Research Communications. 21(5). 361–368. 8 indexed citations
4.
Mills, P. C., et al.. (1997). Stress response to chronic inflammation in the horse. Equine Veterinary Journal. 29(6). 483–486. 26 indexed citations
5.
Mills, P. C., et al.. (1996). The effect of inflammation on the disposition of phenylbutazone in Thoroughbred horses. Journal of Veterinary Pharmacology and Therapeutics. 19(6). 475–481. 8 indexed citations
6.
Seawright, A. A., et al.. (1995). Phenylbutazone in racing Greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration. Australian Veterinary Journal. 72(8). 304–308. 1 indexed citations
7.
Mills, Paul C., J. C. Ng, Joseph Thornton, A. A. Seawright, & D. E. AUER. (1994). Exercise-induced connective tissue turnover and lipid peroxidation in horses. British Veterinary Journal. 150(1). 53–63. 19 indexed citations
8.
AUER, D. E., et al.. (1993). Vascular leakage induced by histamine, bradykinin, serotonin and prostaglandin E2 in Greyhounds. Australian Veterinary Journal. 70(1). 21–24. 7 indexed citations
9.
AUER, D. E., et al.. (1993). Detection of bicarbonate administration (milkshake) in Standardbred horses. Australian Veterinary Journal. 70(9). 336–340. 36 indexed citations
10.
AUER, D. E., et al.. (1993). Free radical oxidation products in plasma and synovial fluid of horses with synovial inflammation. Australian Veterinary Journal. 70(2). 49–52. 14 indexed citations
11.
AUER, D. E., et al.. (1991). Assessment of histamine, bradykinin, prostaglandins E1 and E2 and carrageenin as vascular permeability agents in the horse. Journal of Veterinary Pharmacology and Therapeutics. 14(1). 61–69. 11 indexed citations
12.
AUER, D. E., et al.. (1990). Copper salicylate and copper phenylbutazone as topically applied anti‐inflammatory agents in the rat and horse. Journal of Veterinary Pharmacology and Therapeutics. 13(1). 67–75. 8 indexed citations
13.
AUER, D. E., et al.. (1990). Superoxide production by stimulated equine polymorphonuclear leukocytes‐inhibition by anti‐inflammatory drugs. Journal of Veterinary Pharmacology and Therapeutics. 13(1). 59–66. 9 indexed citations
14.
AUER, D. E., et al.. (1990). Effect of Palosein (superoxide dismutase) and catalase upon oxygen derived free radical induced degradation of equine synovial fluid. Equine Veterinary Journal. 22(1). 13–17. 11 indexed citations
15.
AUER, D. E., et al.. (1988). Monthly variation in the plasma copper and zinc concentration of pregnant and non‐pregnant mares. Australian Veterinary Journal. 65(2). 61–62. 8 indexed citations
16.
Patterson, Scott D., D. E. AUER, & K. Bell. (1988). Acute phase response in the horse: plasma protein changes associated with adjuvant induced inflammation.. PubMed. 17(2). 257–64. 12 indexed citations
17.
AUER, D. E., et al.. (1988). Assessment of copper and zinc status of farm horses and training thoroughbreds in south‐east Queensland. Australian Veterinary Journal. 65(10). 317–320. 18 indexed citations
18.
AUER, D. E., et al.. (1987). Glucose metabolism in a pony mare with a tumour of the pituitary gland pars intermedia. Australian Veterinary Journal. 64(12). 379–382. 9 indexed citations
19.
AUER, D. E., et al.. (1985). Pharyngeal lymphoid hyperplasia in Thoroughbred racehorses in training. Australian Veterinary Journal. 62(4). 124–126. 16 indexed citations
20.
AUER, D. E., A. A. Seawright, C. C. Pollitt, & Gavin Williams. (1984). Illness in horses following spraying with amitraz. Australian Veterinary Journal. 61(8). 257–259. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jim Moore Breakdown of academic impact, for papers by Michael L. Keowen Breakdown of academic impact, for papers by Qiao Zhong Breakdown of academic impact, for papers by L.K. Warren Breakdown of academic impact, for papers by Toshinori Sako Breakdown of academic impact, for papers by Faith E. Hughes Breakdown of academic impact, for papers by Ramberg Cf Breakdown of academic impact, for papers by Chadwick E. Dodd Breakdown of academic impact, for papers by Christopher Macdonald Breakdown of academic impact, for papers by Tisha A.M. Harper
Rankless by CCL
2026